• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-199a-5p模拟物靶向多发性骨髓瘤相关血管生成:体内外抗肿瘤活性

Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity.

作者信息

Raimondi Lavinia, Amodio Nicola, Di Martino Maria Teresa, Altomare Emanuela, Leotta Marzia, Caracciolo Daniele, Gullà Annamaria, Neri Antonino, Taverna Simona, D'Aquila Patrizia, Alessandro Riccardo, Giordano Antonio, Tagliaferri Pierosandro, Tassone Pierfrancesco

机构信息

Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy.

出版信息

Oncotarget. 2014 May 30;5(10):3039-54. doi: 10.18632/oncotarget.1747.

DOI:10.18632/oncotarget.1747
PMID:24839982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4102790/
Abstract

Multiple myeloma (MM) cells induce relevant angiogenic effects within the human bone marrow milieu (huBMM) by the aberrant expression of angiogenic factors. Hypoxia triggers angiogenic events within the huBMM and the transcription factor hypoxia-inducible factor-1α (HIF-1α) is over-expressed by MM cells. Since synthetic miR-199a-5p mimics negatively regulates HIF-1α, we here investigated a miRNA-based therapeutic strategy against hypoxic MM cells. We indeed found that enforced expression of miR-199a-5p led to down-modulated expression of HIF-1α as well as of other pro-angiogenic factors such as VEGF-A, IL-8, and FGFb in hypoxic MM cells in vitro. Moreover, miR-199a-5p negatively affected MM cells migration, while it increased the adhesion of MM cells to bone marrow stromal cells (BMSCs) in hypoxic conditions. Furthermore, transfection of MM cells with miR-199a-5p significantly impaired also endothelial cells migration and down-regulated the expression of endothelial adhesion molecules such as VCAM-1 and ICAM-1. Finally, we identified a hypoxia\AKT/miR-199a-5p loop as a potential molecular mechanism responsible of miR-199a-5p down-regulation in hypoxic MM cells. Taken together our results indicate that miR-199a-5p has an important role for the pathogenesis of MM and support the hypothesis that targeting angiogenesis via a miRNA/HIF-1α pathway may represent a novel potential therapeutical approach for this still lethal disease.

摘要

多发性骨髓瘤(MM)细胞通过血管生成因子的异常表达在人骨髓微环境(huBMM)中诱导相关的血管生成效应。缺氧触发huBMM内的血管生成事件,并且MM细胞过表达转录因子缺氧诱导因子-1α(HIF-1α)。由于合成的miR-199a-5p模拟物负向调节HIF-1α,我们在此研究了一种针对缺氧MM细胞的基于miRNA的治疗策略。我们确实发现,在体外缺氧的MM细胞中,miR-199a-5p的强制表达导致HIF-1α以及其他促血管生成因子如VEGF-A、IL-8和FGFb的表达下调。此外,miR-199a-5p对MM细胞迁移产生负面影响,而在缺氧条件下它增加了MM细胞与骨髓基质细胞(BMSC)的黏附。此外,用miR-199a-5p转染MM细胞也显著损害内皮细胞迁移,并下调内皮黏附分子如VCAM-1和ICAM-1的表达。最后,我们确定了一个缺氧\AKT/miR-199a-5p环作为缺氧MM细胞中miR-199a-5p下调的潜在分子机制。综上所述,我们的结果表明miR-199a-5p在MM发病机制中起重要作用,并支持通过miRNA/HIF-1α途径靶向血管生成可能代表这种仍然致命疾病的一种新型潜在治疗方法的假设。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c51/4102790/9c3a8f806628/oncotarget-05-3039-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c51/4102790/d615d762febd/oncotarget-05-3039-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c51/4102790/4391aec80d5d/oncotarget-05-3039-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c51/4102790/b00ed95f974c/oncotarget-05-3039-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c51/4102790/8d16ef870139/oncotarget-05-3039-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c51/4102790/033d744c21cc/oncotarget-05-3039-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c51/4102790/a30995181a69/oncotarget-05-3039-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c51/4102790/f2930f2d7cfa/oncotarget-05-3039-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c51/4102790/9c3a8f806628/oncotarget-05-3039-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c51/4102790/d615d762febd/oncotarget-05-3039-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c51/4102790/4391aec80d5d/oncotarget-05-3039-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c51/4102790/b00ed95f974c/oncotarget-05-3039-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c51/4102790/8d16ef870139/oncotarget-05-3039-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c51/4102790/033d744c21cc/oncotarget-05-3039-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c51/4102790/a30995181a69/oncotarget-05-3039-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c51/4102790/f2930f2d7cfa/oncotarget-05-3039-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c51/4102790/9c3a8f806628/oncotarget-05-3039-g008.jpg

相似文献

1
Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity.miR-199a-5p模拟物靶向多发性骨髓瘤相关血管生成:体内外抗肿瘤活性
Oncotarget. 2014 May 30;5(10):3039-54. doi: 10.18632/oncotarget.1747.
2
miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF.miR-15a 和 miR-16 通过靶向 VEGF 影响多发性骨髓瘤的血管生成。
Carcinogenesis. 2013 Feb;34(2):426-35. doi: 10.1093/carcin/bgs333. Epub 2012 Oct 26.
3
MiR-199a inhibits the angiogenic potential of endometrial stromal cells under hypoxia by targeting HIF-1α/VEGF pathway.微小RNA-199a通过靶向缺氧诱导因子-1α/血管内皮生长因子途径抑制缺氧条件下子宫内膜基质细胞的血管生成潜能。
Int J Clin Exp Pathol. 2015 May 1;8(5):4735-44. eCollection 2015.
4
The HIF-1/SNHG1/miR-199a-3p/TFAM axis explains tumor angiogenesis and metastasis under hypoxic conditions in breast cancer.缺氧条件下 HIF-1/SNHG1/miR-199a-3p/TFAM 轴解释乳腺癌中的肿瘤血管生成和转移。
Biofactors. 2021 May;47(3):444-460. doi: 10.1002/biof.1702. Epub 2021 May 18.
5
miR-140-5p Attenuates Hypoxia-Induced Breast Cancer Progression by Targeting Nrf2/HO-1 Axis in a Keap1-Independent Mechanism.miR-140-5p 通过 Keap1 非依赖机制靶向 Nrf2/HO-1 轴抑制低氧诱导的乳腺癌进展。
Cells. 2021 Dec 22;11(1):12. doi: 10.3390/cells11010012.
6
[miR-199a-5p inhibits the proliferation of rat airway smooth muscle cells and the expression of hypoxia inducible factor 1 alpha under hypoxia conditions].[微小RNA-199a-5p在缺氧条件下抑制大鼠气道平滑肌细胞增殖及缺氧诱导因子1α表达]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2015 Sep;31(9):1183-8.
7
MiR-199a-5p Deficiency Promotes Artery Restenosis in Peripheral Artery Disease by Regulating ASMCs Function Targeting HIF-1α and E2F3.miR-199a-5p 通过调控 HIF-1α 和 E2F3 靶向 ASMCs 功能促进外周动脉疾病中的动脉再狭窄。
Curr Vasc Pharmacol. 2024;22(5):342-354. doi: 10.2174/0115701611280634240616062413.
8
Long noncoding RNA SNHG12 promotes vascular smooth muscle cell proliferation and migration via regulating miR-199a-5p/HIF-1α.长链非编码 RNA SNHG12 通过调控 miR-199a-5p/HIF-1α 促进血管平滑肌细胞增殖和迁移。
Cell Biol Int. 2020 Aug;44(8):1714-1726. doi: 10.1002/cbin.11365. Epub 2020 May 11.
9
LncRNA TMPO-AS1 up-regulates the expression of HIF-1α and promotes the malignant phenotypes of retinoblastoma cells via sponging miR-199a-5p.长链非编码 RNA TMPO-AS1 通过海绵吸附 miR-199a-5p 上调 HIF-1α 的表达,促进视网膜母细胞瘤细胞的恶性表型。
Pathol Res Pract. 2020 Apr;216(4):152853. doi: 10.1016/j.prp.2020.152853. Epub 2020 Feb 5.
10
Influence of miR-199a on rats with non-small cell lung cancer via regulating the HIF-1α/VEGF signaling pathway.miR-199a 通过调控 HIF-1α/VEGF 信号通路对非小细胞肺癌大鼠的影响。
Eur Rev Med Pharmacol Sci. 2019 Dec;23(23):10363-10369. doi: 10.26355/eurrev_201912_19675.

引用本文的文献

1
Regulation of Cancer-Associated miRNAs Expression under Hypoxic Conditions.缺氧条件下癌症相关 miRNAs 表达的调控。
Anal Cell Pathol (Amst). 2024 May 10;2024:5523283. doi: 10.1155/2024/5523283. eCollection 2024.
2
MiRNA as a Potential Target for Multiple Myeloma Therapy-Current Knowledge and Perspectives.微小RNA作为多发性骨髓瘤治疗的潜在靶点——当前认知与展望
J Pers Med. 2022 Aug 31;12(9):1428. doi: 10.3390/jpm12091428.
3
Metabolic cross-talk within the bone marrow milieu: focus on multiple myeloma.骨髓微环境中的代谢相互作用:聚焦于多发性骨髓瘤。

本文引用的文献

1
Chemokines in tumor progression and metastasis.趋化因子在肿瘤进展和转移中的作用
Oncotarget. 2013 Dec;4(12):2171-85. doi: 10.18632/oncotarget.1426.
2
miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells.微小RNA-29b通过启动子去甲基化诱导细胞因子信号转导抑制因子-1表达,并对多发性骨髓瘤细胞和内皮细胞的迁移发挥负向调节作用。
Cell Cycle. 2013 Dec 1;12(23):3650-62. doi: 10.4161/cc.26585. Epub 2013 Sep 25.
3
microRNA-mediated regulation of the tumor microenvironment.微小 RNA 介导的肿瘤微环境调控。
Exp Hematol Oncol. 2022 Sep 1;11(1):49. doi: 10.1186/s40164-022-00303-z.
4
Epigenetic Crosstalk between Malignant Plasma Cells and the Tumour Microenvironment in Multiple Myeloma.多发性骨髓瘤中恶性浆细胞与肿瘤微环境之间的表观遗传串扰
Cancers (Basel). 2022 May 24;14(11):2597. doi: 10.3390/cancers14112597.
5
The Multiple Myeloma Landscape: Epigenetics and Non-Coding RNAs.多发性骨髓瘤全景:表观遗传学与非编码RNA
Cancers (Basel). 2022 May 10;14(10):2348. doi: 10.3390/cancers14102348.
6
Research Advances on Matrine.苦参碱的研究进展
Front Chem. 2022 Apr 1;10:867318. doi: 10.3389/fchem.2022.867318. eCollection 2022.
7
MT-12 inhibits the growth and metastasis of bladder cancer cells via suppressing tumor angiogenesis and .MT-12通过抑制肿瘤血管生成等过程来抑制膀胱癌细胞的生长和转移。
Transl Cancer Res. 2019 Feb;8(1):120-129. doi: 10.21037/tcr.2019.01.12.
8
One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies.一种组学方法并不能解决所有问题:代谢组学与表观基因组学在血液系统恶性肿瘤中携手合作。
Epigenomes. 2021 Oct 8;5(4):22. doi: 10.3390/epigenomes5040022.
9
Clinicopathologic and molecular analysis of a undifferentiated sarcoma of the kidney reveals significant epigenetic alterations.对肾未分化肉瘤的临床病理和分子分析显示存在显著的表观遗传改变。
Cold Spring Harb Mol Case Stud. 2022 Jan 10;8(1). doi: 10.1101/mcs.a005942. Print 2022 Jan.
10
MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease.微小RNA作为从无症状多发性骨髓瘤向有症状多发性骨髓瘤转变的一种潜在新预防方法。
Cancers (Basel). 2021 Jul 21;13(15):3650. doi: 10.3390/cancers13153650.
Cell Cycle. 2013 Oct 15;12(20):3262-71. doi: 10.4161/cc.26087. Epub 2013 Aug 26.
4
Hypoxia-induced snail expression through transcriptional regulation by HIF-1α in pancreatic cancer cells.缺氧诱导的胰腺癌细胞中 snail 表达通过 HIF-1α 的转录调控。
Dig Dis Sci. 2013 Dec;58(12):3503-15. doi: 10.1007/s10620-013-2841-4. Epub 2013 Aug 25.
5
Emerging pathways as individualized therapeutic target of multiple myeloma.多发性骨髓瘤的个体化治疗靶点的新兴途径。
Expert Opin Biol Ther. 2013 Jun;13 Suppl 1:S95-109. doi: 10.1517/14712598.2013.807338. Epub 2013 Jun 6.
6
Non-coding RNA: a novel opportunity for the personalized treatment of multiple myeloma.非编码 RNA:多发性骨髓瘤个体化治疗的新机遇。
Expert Opin Biol Ther. 2013 Jun;13 Suppl 1:S125-37. doi: 10.1517/14712598.2013.796356. Epub 2013 May 22.
7
New strategies in the treatment of multiple myeloma.多发性骨髓瘤的治疗新策略。
Clin Cancer Res. 2013 Jul 1;19(13):3337-44. doi: 10.1158/1078-0432.CCR-12-1881. Epub 2013 Mar 20.
8
In vitro and in vivo anti-tumor activity of miR-221/222 inhibitors in multiple myeloma.miR-221/222抑制剂在多发性骨髓瘤中的体外和体内抗肿瘤活性
Oncotarget. 2013 Feb;4(2):242-55. doi: 10.18632/oncotarget.820.
9
Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth.靶向 miR-21 抑制体外和体内多发性骨髓瘤细胞生长。
Clin Cancer Res. 2013 Apr 15;19(8):2096-106. doi: 10.1158/1078-0432.CCR-12-3325. Epub 2013 Feb 27.
10
Hypoxia-inducible factor (HIF)-1α suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction.缺氧诱导因子 (HIF)-1α 抑制骨髓瘤细胞在体内阻断肿瘤生长,抑制血管生成和骨质破坏。
Leukemia. 2013 Aug;27(8):1697-706. doi: 10.1038/leu.2013.24. Epub 2013 Jan 24.